The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics

Clinical Research in Cardiology

Volumn 98, Issue 7, 2009, Pages 421-433

  Cowan, Brett R ^a   Young, Alistair A ^a   Anderson, Craig ^a,b   Doughty, Robert N ^a   Krittayaphong, Rungroj ^c   Lonn, Eva ^d   Marwick, Thomas H ^e   Reid, Chris M ^h,i   Sanderson, John E ^f   Schmieder, Roland E ^g   Teo, Koon ^d   Wadham, Angela K ^a   Worthley, Stephen G ^j   Yu, Cheuk Man ^k   Yusuf, Salim ^d   Jennings, Garry L ^h  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

ⁱ MONASH UNIVERSITY   (Australia)

^j ROYAL ADELAIDE HOSPITAL   (Australia)

^k CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Cardiac MRI; Left ventricular dysfunction; ONTARGET; Ramipril; Telmisartan; TRANSCEND; Trials

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TELMISARTAN;

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSENSUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; ETHNICITY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC PRESSURE; HEART PROTECTION; HEART VENTRICLE PRESSURE; HISTORY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; QUALITY CONTROL; RAMIPRIL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67651248208     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0014-4     Document Type: Article

References (44)

1. K Reddy S Yusuf 1998 Emerging epidemic of cardiovascular disease in developing countries Circulation 97 596 601
2. D Levy R Garrison D Savage W Kannel W Castelli 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1561 1566
3. H White R Norris M Brown P Brandt R Whitlock C Wild 1987 Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 76 44 51
4. RB Devereux MH Alderman 1993 Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events Circulation 88 1444 1455
5. MJ Koren RB Devereux PN Casale DD Savage JH Laragh 1991 Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 114 345 352
6. D Levy JM Murabito KM Anderson JC Christiansen WP Castelli 1994 Echocardiographic left ventricular hypertrophy: clinical characteristics: the Framingham heart study Clin Exp Hypertens Part A Theory Pract 14 85 97
7. M Bikkina D Levy JC Evans MG Larson EJ Benjamin PA Wolf 1994 Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study JAMA 272 33 36 (Pubitemid 24195443)
8. JK Ghali Y Liao B Simmons A Castaner G Cao RS Cooper 1992 The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease Ann Intern Med 117 831 836
9. L Bolognese P Dellavesa L Rossi G Sarasso AS Bongo MC Scianaro 1994 Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease Am J Cardiol 73 1 5
10. E Laufer GL Jennings PI Korner E Dewar 1989 Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension Hypertension 13 151 162
11. ML Muiesan M Salvetti D Rizzoni M Castellan F Donato E Agabiti-Rosei 1995 Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment J Hypertens 13 1091 1095
12. P Verdecchia G Schillaci C Borgioni A Ciucci R Gattobigio I Zampi 1998 Prognostic significance of serial changes in left ventricular mass in essential hypertension Circulation 97 48 54 (Pubitemid 28036154)
13. RB Devereux K Wachtell E Gerdts K Boman MS Nieminen V Papademetriou J Rokkedal K Harris P Aurup B Dahlof 2004 Prognostic significance of left ventricular mass change during treatment of hypertension JAMA 292 2350 2356
14. P Gosse O Dubourg P Gueret 2003 Regression of left ventricular hypertrophy with echocardiography: some lessons from the LIVE study J Hypertens 21 217 221
15. AU Klingbeil MP Schneider P Martus FH Messereli RE Schmieder 2001 Treatment of left ventricular hypertrophy: meta-analysis of all randomised double-blind studies until 2000 (abstract) J Am Soc Nephrol 12 485A
16. PM Okin RB Devereux S Jern SE Kjeldsen S Julius MS Nieminen 2003 Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study Circulation 108 684 690
17. The ONTARGET Investigators 2008 Telmisartan, ramipril or both in patients at high risk for vascular events New Engl J Med 358 1547 1559
18. The TRANSCEND Investigators 2008 Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial Lancet 372 1174 1183
19. The HOPE Study Investigators 2000 Effects of an angiotensin- convertingenzyme inhibitor, ramipril, on CV events in high-risk patients N Engl J Med 342 145 153
20. E Lonn R Shaikholeslami Q Yi J Bosch B Sullivan P Tanser A Magi S Yusuf 2004 Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction. A substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial J Am Coll Cardiol 43 2200 2206
21. C Anderson 2005 Rationale and design of the cardiac magnetic resonance imaging substudy of the ONTARGET trial programme J Int Med Res 33 Suppl 1 50A 57A
22. P Pattynama A De Roos E Van der Wall A Van Voorthuisen 1994 Evaluation of cardiac function with magnetic resonance imaging Am Heart J 128 595 607
23. SG Myerson NG Bellenger DJ Pennell 2002 Assessment of left ventricular mass by cardiovascular magnetic resonance Hypertension 39 750 755
24. P Bottini A Carr L Prisant F Flickinger J Allison J Gottdiener 1995 Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient Am J Hypertens 8 221 228
25. PMT Pattynama HJ Lamb EA van der Velde EE van der Wall A de Roos 1993 Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis Radiology 187 261 268
26. N Reichek 1991 Magnetic resonance imaging for assessment of myocardial function Magn Reson Q 7 255 274
27. D Fieno W Jaffe O Simonetti R Judd J Finn 2002 TrueFISP: assessment of accuracy for measurement of left ventricular mass in an animal model J Mag Reson Imaging 15 526 531
28. AN Weaver HU Jones GK Jelaco JA Cha J Hall K Walker DD Blatter JL Anderson 2006 Magnitude and causes of interobserver discrepancies in CMR volume measurements: critical importance of choice of the basal slice J Cardiovasc Magn Reson 8 82 83
29. TN Bloomer S Plein A Radjenovic DM Higgins TR Jones JP Ridgway MU Sivananthan 2001 Cine MRI using steady state free precession in the radial long axis orientation is a fast accurate method for obtaining volumetric data of the left ventricle J Magn Reson Imaging 14 685 692
30. A Young B Cowan S Thrupp W Hedley L Dell'Italia 2000 Left ventricular mass and volume: Fast calculation with guide-point modeling on MR images Radiology 216 597 602
31. I Rodriguez DB Ennis H Wen 2006 Noninvasive measurement of myocardial tissue volume change during systolic contraction and diastolic relaxation in the canine left ventricle Magn Reson Med 55 484 490
32. F Grothues GC Smith JCC Moon NG Bellenger P Collins HU Klein DJ Pennell 2002 Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 29 34
33. RA Stewart R Gabriel OC Raffel BR Cowan AA Young G Whalley C Occleshaw I Zeng A Kerr 2007 Influence of beta-blockade on mitral regurgitant volume in patients with degenerative mitral valve prolapse Circulation 116 II-680
34. RE Schmieder MP Schlaich AU Klingbeil P Martus 1998 Update on reversal of left ventricular hypertrophy in essential hypertension (a meta analysis of all randomized double-blind studies until December 1996) Nephrol Dial Transplant 13 564 569
35. RB Devereux V Palmieri N Sharpe V De Quattro JN Bella G de Simone 2001 Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial Circulation 104 1248 1254
36. D Galzerano P Tammaro L del Viscovo D Lama A Galzerano R Breglio B Tuccillo G Paolisso P Capogrosso 2005 Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study Am J Hypertens 18 1563 1569
37. F Turnbull B Neal M Pfeffer J Kostis C Algert M Woodward J Chalmers A Zanchetti S MacMahon 2007 Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system J Hypertens 25 951 958
38. C Werner M Baumhäkel KK Teo R Schmieder J Mann T Unger S Yusuf M Böhm 2008 RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection Clin Res Cardiol 97 4 244 252
39. S Clay K Alfakih DR Messroghli T Jones JP Ridgway MU Sivananthan 2006 The reproducibility of left ventricular volume and mass measurements: a comparison between dual-inversion-recovery black-blood sequence and SSFP Eur Radiol 16 32 37
40. H Steen K Nasir E Flynn I El-Shehaby S Lai HA Katus D Bluemcke JA Lima 2007 Is magnetic resonance imaging the 'reference standard' for cardiac functional assessment? Factors influencing measurement of left ventricular mass and volumes Clin Res Cardiol 96 10 743 751
41. C Lorenz E Walker V Morgan S Klein T Graham 1999 Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging J Cardiovasc Magn Reson 1 7 21
42. B Sievers S Kirchberg A Bakan U Franken H-J Trappe 2004 Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance J Cardiovasc MR 6 9 16 (Pubitemid 38316423)
43. GA Stewart J Foster M Cowan E Rooney T McDonagh HJ Dargie RS Rodger AG Jardine 1999 Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging Kidney Int 56 2248 2253
44. W Tseng T Liao J Wang 2002 Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging J Cardiovasc Magn Reson 4 443 457